2023 SEA TO SEA TOUR INFORMATION COMING SOON!
SEA TO SEA FOR MBC VIRTUAL TOUR
Climb aboard our virtual RV and join METAvivor board member, Kelly Shanahan, M.D. as she "tours the country interviewing previous METAvivor grant recipients for updates on how 100% of your donations are doing more for stage IV and advancing metastatic breast cancer research.
Sea to Sea 4 MBC is METAvivor's signature program that brings resources and information to those living with metastatic breast cancer and raises awareness about the disease. Patients, caregivers and friends hop aboard the Mets Mobile (a small RV wrapped in MBC colors and information about MBC) and travel across the U.S. sharing their stories, sharing facts about MBC providing information about clinical trials and sharing resources with people along the way. We need drivers, planners and interested friends to help us make this the best year back on the road! If you're interested in volunteering, please reach out to [email protected]
Climb aboard our virtual RV and join METAvivor board member, Kelly Shanahan, M.D. as she "tours the country interviewing previous METAvivor grant recipients for updates on how 100% of your donations are doing more for stage IV and advancing metastatic breast cancer research.
Professor and Co-Director Breast Cancer Program, Case Comprehensive Cancer Center, Case Western Reserve University.
Professor and Chair ad interim, Department of Molecular and Cellular Oncology
Hubert L. & Olive Stringer Distinguished Chair in Basic Science
University Distinguished Teaching Professor, The Univ. Texas M. D. Anderson Cancer Center
Assistant Professor in the Department of Radiation Oncology at Ohio State, member of the Cancer Biology Program at OSUCCC - James, and the first recipient of the Block Lectureship Junior Faculty Award.
Professor with Tenure, Grohne Endowed Chair in Cancer, University of Colorado Denver. Department of Pharmacology, Associate Director of Basic Research, University of Colorado Cancer Center.
Founding director of the Department of Cancer Biology for the University of Kansas Medical Center (KUMC), Professor and Chair, Adjunct Faculty Department of Molecular and Integrative Physiology at KUMC, Member of METAvivor's Scientific Advisory Board.
For more interviews, please visit the METAvivor YouTube Channel
1. Conduct training and outreach to those with metastatic breast cancer (MBC) with a focus on underserved metastatic breast cancer patients;
2. Provide education and materials to the public about METAvivor, MBC and the need for additional research funding;
3. Train MBC patients on advocacy and advocacy iniitatives; and
4. Visit cancer centers, partners and collaborators to share information about METAvivor’s research grants, encourage researchers to pursue MBC research grant awards and visit with top MBC researchers.
METAvivor will be in the Metastatic Breast Cancer Mobile for this important program. The #METAvivorMobile will be loaded with information about MBC, clinical trials, advocacy initiatives and peer support programs. This year, we will visit 14 states and attend 20 events. Participate in contests to guess where the #METAvivorMobile, join us for a ride-a-long and share the events through social media using #C2C4MBC, #DONTIGNORESTAGEIV, #C2Cinyourcity and #METAviviorMobile.
In 2015, METAvivor launched our first Sea to Sea for MBC Campaign, a cross-country trip designed to raise awareness about metastatic breast cancer. Volunteers and METAvivor Board members traveled across the country to speak with MBC patients and caregivers, to visit the research centers where we have funded MBC grants, and to attend speaking engagements to raise awareness and educate the public about MBC.
Our 2015 Sea to Sea for MBC campaign was a great success, enabling us to visit 26 cities across the country to spread the word about getting MBC the funding it deserves.
Our 2015 campaign was just the beginning—we expect the launch of our 2017 Sea to Sea for MBC Advocacy campaign will deliver even more information.
Sponsored by Lilly Oncology - More for MBC, Seattle Genetics, Astrazenaca, and Macrogenics.
